Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04542239 · ClinicalTrials.gov registry record
Inclined Positioning and Infant Gastroesophageal Reflux
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 35
- Enrollment target
NCT04542239: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04542239 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04542239 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose of this voluntary research study is to evaluate the extent to which infants with Gastroesophageal Reflux (GER) exhibit oxygen desaturation (low oxygen levels in their blood) and bradycardia (slow heart rate) in supine (lying flat on back) and inclined positions.
Primary Outcome
Evaluate the extent to which infants exhibit oxygen desaturation (oxygen saturation \<94%) in each position
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2022-01-25 |
What the finished NCT04542239 record still lists
NCT04542239 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04542239 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04542239 about?
NCT04542239 is a clinical study titled "Inclined Positioning and Infant Gastroesophageal Reflux". The purpose of this voluntary research study is to evaluate the extent to which infants with Gastroesophageal Reflux (GER) exhibit oxygen desaturation (low oxygen levels in their blood) and bradycardia (slow heart rate) in supine (lying flat on back) and inclined positions.
What is the current status of trial NCT04542239?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2021-03-15. Estimated completion is 2022-01-25.
Who is sponsoring clinical trial NCT04542239?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI